Fig. 5
From: Changes of N6-methyladenosine modulators promote breast cancer progression
The prognostic value of mRNA level of m6A enzymes in BC (bc-GenExMiner v4.0). Reduced mRNA level of METTL3 (a), METTL14 (b), WTAP (c) and FTO (d) but not ALKBH5 (e) was significantly associated with poor metastasis relapse (MR)-free survival in all BC patients